NSC |
Compound |
Enrichment |
Correlation |
NSC 664401 |
Null |
0.0278435641331424 |
0.28538426 |
NSC 667471 |
Null |
0.0278435641331424 |
0.34168792 |
NSC 670656 |
4a,14a-Epoxy-4,14-[3]hexene[1,5]diynonaphtho[2,3-c] phenanthridine-3,7,12(4H)-trione, 1,2,13,14-tetrahydro-4,6-dihydroxy-1-methyl-, stereoisomer |
0.0278435641331424 |
0.22204729 |
NSC 670804 |
Null |
0.0278435641331424 |
-0.16593373 |
NSC 673828 |
Null |
0.0278435641331424 |
0.24652626 |
NSC 690266 |
ANTINEOPLASTIC-690266 |
0.0278435641331424 |
0.28275665 |
NSC 697140 |
Null |
0.0278435641331424 |
0.32564048 |
NSC 699222 |
2-Quinoxalinecarbonitrile, 7-(4-nitrophenyl)-3-[4-(4-nitrophenyl)-1-piperazinyl]-, 1,4-dioxide |
0.0278435641331424 |
0.10624566 |
NSC 702208 |
Spiro[benzo[1,2-b:5,4-c']dipyran-2(3H),2'(3'H)-naphtho[2,3- b]furan]-7-carboxylic acid, 3'-[(2,6-dideoxy-3-O-methylhexo pyranosyl)oxy]-4,5',8',9-tetrahydro-3,4',9',10-tetrahydroxy-7'-methoxy-5',8',9- |
0.0278435641331424 |
0.37022071 |
NSC 287459 |
Cytarabine AY |
0.0304779558345019 |
0.22671755 |